An increase in A1 astrocytes expressing complement C3 has been observed in PD brains, and treatment of astrocytes in vitro with cytokines TNF-α, IL-1α and C1q resulted in a shift to A1 astrocytes, leading to a loss of their ability to maintain neuronal survival [19]. This evidence concerns the gene C3 and Parkinson disease.